Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Clin Chim Acta. 2016 Mar 3;456:128–136. doi: 10.1016/j.cca.2016.02.022

Table 3.

Clinical specificity of HM-ELISA+PSAM with cut-off 4 for plasma and serum samples.

Sample type Method used Total samples Negative by test False positives Clinical Specificity, %
Plasma HM-ELISA+PSAM 50 49 1 98
Serum HM-ELISA+PSAM 26 26 0 100
Total HM-ELISA+PSAM 76 75 1 98.68